Evidence map›Paper›PMID 42396392›Full record

ArticleClinical case reports2026

Could Fabry Disease Cause Giant Coronary Aneurysms in a 7-Month-Old Infant: A Case Report.

Reza Shabanian, Minoo Dadkhah, Rana Doroudian, Mehrnaz Adib, Sahar Naderi, Khashayar Ashkboos

Abstract read
In one paragraph

Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Reza ShabanianDepartment of Pediatric Cardiology, Hakim Children's Hospital Tehran University of Medical Sciences Tehran Iran.
Minoo DadkhahDepartment of Pediatric Cardiology, Hakim Children's Hospital Tehran University of Medical Sciences Tehran Iran.
Rana DoroudianDepartment of Pediatric Endocrinology, Hakim Children's Hospital Tehran University of Medical Sciences Tehran Iran.
Mehrnaz AdibDepartment of Pediatric Rheumatology, Hakim Children's Hospital Tehran University of Medical Sciences Tehran Iran.
Sahar NaderiDepartment of Pediatric Rheumatology, Hakim Children's Hospital Tehran University of Medical Sciences Tehran Iran.
Khashayar AshkboosDepartment of Medicine Tehran University of Medical Sciences Tehran Iran.ORCID https://orcid.org/0000-0003-0563-6000

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fabry disease is a rare X-linked lysosomal storage disorder that can affect multiple organs. Cardiac involvement, one of its significant manifestations, can begin in childhood and is more prevalent in males, with severity increasing with age and disease progression. The most common cardiac feature in childhood is left ventricular hypertrophy (LVH), a significant contributor to morbidity and early mortality in adulthood. Other cardiac complications in Fabry disease include atrial fibrillation, ventricular tachycardia, conduction abnormalities, valvular insufficiency, hypertension, and coronary artery disease (CAD). While life-threatening cardiac symptoms are typically absent in children, accelerated atherosclerosis can lead to CAD in adults. No prior reports have documented coronary artery disease in pediatric Fabry disease patients. We present the case of a 7-month-old infant who was admitted with prolonged fever, elevated inflammatory markers, and giant coronary artery aneurysms. Initially diagnosed and treated as atypical Kawasaki disease, further investigations identified a GLA mutation, suggesting Fabry disease as a possible contributing factor.

Indexed as

coronary artery aneurysmsFabry diseaseKawasaki diseaseprolonged fever

Identifiers

PMID42396392
PMCPMC13323576

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.